Publications by authors named "Rachel Borson"

Claim this Profile
P
Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer.
Rachel Borson, Graydon Harker, James Reeves, Thaddeus Beck, Steven Hager

Clin Breast Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy.
Howard A Burris, Hope S Rugo, Svetislava J Vukelja, Charles L Vogel, Rachel A Borson

J Clin Oncol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis